Ovarian Cancer
Ovarian Cancer: is a cancer that ignites in the female organs that produce eggs (ovaries). Ovarian cancer frequently goes undetected until it has spread within the pelvis and belly. At this late stage, ovarian cancer is more severe to treat and can be fatal.
-
APR 10, 2019 12:00 PM PDTC.E. CREDITSAPR 10, 2019 12:00 PM PDTPersonalized medicine driven by genomic-based treatments continues to increase in importance. Representatives from two distinct healthcare entities – a regional reference lab and commun...Speaker: Tony Magliocco, MD , Keith Gligorich, PhDPresented At:Molecular Diagnostics 2019Sponsored By: IlluminaDEC 19, 2018 05:00 PM CSTC.E. CREDITSDEC 19, 2018 05:00 PM CSTDATE: December 20, 2018TIME: 09:00am CST, 10:00am JST Host cell protein (HCP) is a significant class of process-related impurity that needs to be removed to adequatel...Speaker: Fengqiang Wang, PhDSponsored By: GE Healthcare Life SciencesDEC 18, 2018 07:00 AM PSTC.E. CREDITSDEC 18, 2018 07:00 AM PSTDATE: December 18,2018TIME: 07:00am PST, 10:00am EST, 15:00pm GMT Host cell protein (HCP) is a significant class of process-related impurity that needs to be removed to...Speaker: Fengqiang Wang, PhDSponsored By: GE Healthcare Life SciencesOCT 10, 2018 01:30 PM PDTC.E. CREDITSOCT 10, 2018 01:30 PM PDTSome Abstract...Speaker: Benjamin Haibe-Kains, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 10:30 AM PDTC.E. CREDITSOCT 10, 2018 10:30 AM PDTThe microbiome signatures in the context of gynecologic cancers (endometrial and ovarian) and the potential for their clinical use will be discussed. The use of microfluidic technologies to i...Speaker: Marina Walther-Antonio, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 07:30 AM PDTC.E. CREDITSOCT 10, 2018 07:30 AM PDTMolecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...Speaker: Karin Rodland, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 06:00 AM PDTC.E. CREDITSOCT 10, 2018 06:00 AM PDTWith over 265,000 new cases per year and over 50,000 deaths, breast and ovarian cancers represent a significant health burden in the USA. Prior work has demonstrated that CD4 helper T c...Speaker: Keith Knutson, PhDPresented At:Cancer Research & Oncology 2018APR 26, 2018 08:00 AM PDTC.E. CREDITSAPR 26, 2018 08:00 AM PDTDATE: April 26, 2018TIME: 8:00am PST, 11:00am EST Engineered T cells expressing a tumor antigen-specific receptor have revolutionized the field of cancer therap...Speaker: Kristin Anderson, PhDSponsored By: Thermo Fisher Scientific - Applied BiosystemsFEB 21, 2018 06:00 AM PSTC.E. CREDITSFEB 21, 2018 06:00 AM PSTWe recently reported that HDAC6 is involved in the regulation of a number of immunosuppressive checkpoint proteins, including the Program Death Receptor Ligand 1 (PD-L1). This protein is one...Speaker: Alejandro Villagra, PhDPresented At:Drug Discovery 2018NOV 15, 2017 10:00 AM PSTNOV 15, 2017 10:00 AM PSTDATE: November 15, 2017TIME: 10:00AM PTInteractions between tumor and immune cells in the tumor microenvironment (TME) play a key role in tumor progression and treatment response, with...Speaker: Annelies Laeremans, PhDSponsored By: Advanced Cell DiagnosticsOCT 11, 2017 12:00 PM PDTC.E. CREDITSOCT 11, 2017 12:00 PM PDTImmunotherapy: An unprecedented opportunity-Long-lasting/curative treatments-Lower side effects-Wide applicability-Natural mechanism of action-Locally produced T cell therapies&...Speaker: Brad Nelson, PhDPresented At:Cancer Research & Oncology 2017OCT 11, 2017 06:00 AM PDTC.E. CREDITSOCT 11, 2017 06:00 AM PDTThere has been a great deal of renewed attention in immuno-oncology over the last decade. Therapies for cancer are being developed, approved, and administered that can either initiate,...Speaker: Wendell Jones, PhDPresented At:Cancer Research & Oncology 2017MAY 09, 2017 10:00 AM PDTC.E. CREDITSMAY 09, 2017 10:00 AM PDTDATE: May 9th, 2017TIME: 10:00AM PDT, 1:00PM ETMyeloproliferative neoplasms including myelofibrosis (MF) are characterized by anemia, splenomegaly, bone marrow fibrosis and inflammatory...Speaker: Stephen Oh, MD, PhD , Jennifer Frahm, PhDSponsored By: FluidigmAPR 12, 2017 07:30 AM PDTC.E. CREDITSAPR 12, 2017 07:30 AM PDTAs next generation sequencing has lowered the price of DNA sequencing orders of magnitude below what it cost to create the first consensus human genome, the sheer diversity of human sequence...Speaker: Robert Nussbaum MD, FACP, FACMGPresented At:Molecular Diagnostics 2017FEB 22, 2017 07:30 AM PSTC.E. CREDITSFEB 22, 2017 07:30 AM PSTLaunched in early 2015, the Precision Medicine Initiative (PMI) takes advantage of the progress made in genomic testing – progress largely driven by rapid advances in DNA sequencing tec...Speaker: Laura Koontz, PhDPresented At:Precision Medicine 2017FEB 22, 2017 06:00 AM PSTC.E. CREDITSFEB 22, 2017 06:00 AM PSTThe starting point for an interaction between a patient and a clinician is almost always a set of clinical facts (aka a phenotype). Phenotype-first medicine is the standard way in which the p...Speaker: Marc Williams, MDPresented At:Precision Medicine 2017NOV 04, 2016 10:00 AM PDTC.E. CREDITSNOV 04, 2016 10:00 AM PDTDATE: November 4, 2016 TIME: 10:00am PT, 1:00pm ET How do you develop clinically relevant biomarkers? Systematic tumor profiling with multi-omics tools and rapid analytical...Speaker: Antonia Sepulveda, MD, PhD , Yang Yang, PhD , Tamara Lotan, MDSponsored By: Affymetrix,AffymetrixMAY 12, 2016 07:30 AM PDTC.E. CREDITSMAY 12, 2016 07:30 AM PDTCirculating tumor cells (CTCs) is an emerging source used molecular cancer diagnostics. Through expression profiling of CTCs, it allows a deeper understanding about which metabolic pathways e...Speaker: Siegfried HauchPresented At:Genetics and GenomicsAPR 07, 2016 06:00 AM PDTC.E. CREDITSAPR 07, 2016 06:00 AM PDTWe have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...Speaker: Philip Low, PhDPresented At:Molecular DiagnosticsFEB 04, 2016 10:30 AM PSTC.E. CREDITSFEB 04, 2016 10:30 AM PSTThe reproducibility of animal studies is now critical to ensure that limited resources are used wisely and that efforts yield useable knowledge. At this time, IACUCs and other similar a...Speaker: Vatsala Naageshwaran, MS , Stacy Pritt, DVM, MS, MBA, CPIA, DACAWPresented At:Laboratory Animal SciencesJAN 15, 2016 04:00 AM PSTC.E. CREDITSJAN 15, 2016 04:00 AM PSTDATE: January 15, 2016 TIME: 7am EST, 12pm UK, 1pm CET With an increasing number of biomarkers and, often, limited availability of biopsy material, there is a growing need for multiplexed...Speaker: Matthew Silver, PhDSponsored By: Cell Signaling Technology,Cell Signaling TechnologyNOV 11, 2015 06:00 AM PSTNOV 11, 2015 06:00 AM PSTCancer is complex, but recent findings are yielding a greater understanding of the disease. The tumor suppressor genes BRCA1 and BRCA2 are implicated in breast, ovarian, prostate, and other c...Speaker: Raed Samara, PhDPresented At:Clinical Diagnostics and ResearchSEP 30, 2015 07:30 AM PDTSEP 30, 2015 07:30 AM PDTWe have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...Speaker: Philip Low, PhDPresented At:Cancer Research and OncologyMAY 14, 2015 01:30 PM PDTMAY 14, 2015 01:30 PM PDTGermline cancer genetics became a reality with the cloning of the tumor suppressor gene RB1 for hereditary retinoblastoma in 1986 by Friend and Weinberg. The existence of cancer susceptibili...Speaker: Judy E Garber, MD, MPHPresented At:Genetics and Genomics
APR 10, 2019
12:00 PM PDT
C.E. CREDITS
APR 10, 2019
12:00 PM PDT
Personalized medicine driven by genomic-based treatments continues to increase in importance. Representatives from two distinct healthcare entities – a regional reference lab and commun...
Speaker:
Tony Magliocco, MD
,
Keith Gligorich, PhD
Presented At:Molecular Diagnostics 2019
Sponsored By: Illumina
DEC 19, 2018
05:00 PM CST
C.E. CREDITS
DEC 19, 2018
05:00 PM CST
DATE: December 20, 2018TIME: 09:00am CST, 10:00am JST Host cell protein (HCP) is a significant class of process-related impurity that needs to be removed to adequatel...
Speaker:
Fengqiang Wang, PhD
Sponsored By: GE Healthcare Life Sciences
DEC 18, 2018
07:00 AM PST
C.E. CREDITS
DEC 18, 2018
07:00 AM PST
DATE: December 18,2018TIME: 07:00am PST, 10:00am EST, 15:00pm GMT Host cell protein (HCP) is a significant class of process-related impurity that needs to be removed to...
Speaker:
Fengqiang Wang, PhD
Sponsored By: GE Healthcare Life Sciences
OCT 10, 2018
01:30 PM PDT
C.E. CREDITS
OCT 10, 2018
01:30 PM PDT
Some Abstract...
Speaker:
Benjamin Haibe-Kains, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
10:30 AM PDT
C.E. CREDITS
OCT 10, 2018
10:30 AM PDT
The microbiome signatures in the context of gynecologic cancers (endometrial and ovarian) and the potential for their clinical use will be discussed. The use of microfluidic technologies to i...
Speaker:
Marina Walther-Antonio, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
07:30 AM PDT
C.E. CREDITS
OCT 10, 2018
07:30 AM PDT
Molecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...
Speaker:
Karin Rodland, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
06:00 AM PDT
C.E. CREDITS
OCT 10, 2018
06:00 AM PDT
With over 265,000 new cases per year and over 50,000 deaths, breast and ovarian cancers represent a significant health burden in the USA. Prior work has demonstrated that CD4 helper T c...
Speaker:
Keith Knutson, PhD
Presented At:Cancer Research & Oncology 2018
APR 26, 2018
08:00 AM PDT
C.E. CREDITS
APR 26, 2018
08:00 AM PDT
DATE: April 26, 2018TIME: 8:00am PST, 11:00am EST Engineered T cells expressing a tumor antigen-specific receptor have revolutionized the field of cancer therap...
Speaker:
Kristin Anderson, PhD
Sponsored By: Thermo Fisher Scientific - Applied Biosystems
FEB 21, 2018
06:00 AM PST
C.E. CREDITS
FEB 21, 2018
06:00 AM PST
We recently reported that HDAC6 is involved in the regulation of a number of immunosuppressive checkpoint proteins, including the Program Death Receptor Ligand 1 (PD-L1). This protein is one...
Speaker:
Alejandro Villagra, PhD
Presented At:Drug Discovery 2018
NOV 15, 2017
10:00 AM PST
NOV 15, 2017
10:00 AM PST
DATE: November 15, 2017TIME: 10:00AM PTInteractions between tumor and immune cells in the tumor microenvironment (TME) play a key role in tumor progression and treatment response, with...
Speaker:
Annelies Laeremans, PhD
Sponsored By: Advanced Cell Diagnostics
OCT 11, 2017
12:00 PM PDT
C.E. CREDITS
OCT 11, 2017
12:00 PM PDT
Immunotherapy: An unprecedented opportunity-Long-lasting/curative treatments-Lower side effects-Wide applicability-Natural mechanism of action-Locally produced T cell therapies&...
Speaker:
Brad Nelson, PhD
Presented At:Cancer Research & Oncology 2017
OCT 11, 2017
06:00 AM PDT
C.E. CREDITS
OCT 11, 2017
06:00 AM PDT
There has been a great deal of renewed attention in immuno-oncology over the last decade. Therapies for cancer are being developed, approved, and administered that can either initiate,...
Speaker:
Wendell Jones, PhD
Presented At:Cancer Research & Oncology 2017
MAY 09, 2017
10:00 AM PDT
C.E. CREDITS
MAY 09, 2017
10:00 AM PDT
DATE: May 9th, 2017TIME: 10:00AM PDT, 1:00PM ETMyeloproliferative neoplasms including myelofibrosis (MF) are characterized by anemia, splenomegaly, bone marrow fibrosis and inflammatory...
Speaker:
Stephen Oh, MD, PhD
,
Jennifer Frahm, PhD
Sponsored By: Fluidigm
APR 12, 2017
07:30 AM PDT
C.E. CREDITS
APR 12, 2017
07:30 AM PDT
As next generation sequencing has lowered the price of DNA sequencing orders of magnitude below what it cost to create the first consensus human genome, the sheer diversity of human sequence...
Speaker:
Robert Nussbaum MD, FACP, FACMG
Presented At:Molecular Diagnostics 2017
FEB 22, 2017
07:30 AM PST
C.E. CREDITS
FEB 22, 2017
07:30 AM PST
Launched in early 2015, the Precision Medicine Initiative (PMI) takes advantage of the progress made in genomic testing – progress largely driven by rapid advances in DNA sequencing tec...
Speaker:
Laura Koontz, PhD
Presented At:Precision Medicine 2017
FEB 22, 2017
06:00 AM PST
C.E. CREDITS
FEB 22, 2017
06:00 AM PST
The starting point for an interaction between a patient and a clinician is almost always a set of clinical facts (aka a phenotype). Phenotype-first medicine is the standard way in which the p...
Speaker:
Marc Williams, MD
Presented At:Precision Medicine 2017
NOV 04, 2016
10:00 AM PDT
C.E. CREDITS
NOV 04, 2016
10:00 AM PDT
DATE: November 4, 2016
TIME: 10:00am PT, 1:00pm ET
How do you develop clinically relevant biomarkers?
Systematic tumor profiling with multi-omics tools and rapid analytical...
Speaker:
Antonia Sepulveda, MD, PhD
,
Yang Yang, PhD
,
Tamara Lotan, MD
Sponsored By: Affymetrix,
Affymetrix
MAY 12, 2016
07:30 AM PDT
C.E. CREDITS
MAY 12, 2016
07:30 AM PDT
Circulating tumor cells (CTCs) is an emerging source used molecular cancer diagnostics. Through expression profiling of CTCs, it allows a deeper understanding about which metabolic pathways e...
Speaker:
Siegfried Hauch
Presented At:Genetics and Genomics
APR 07, 2016
06:00 AM PDT
C.E. CREDITS
APR 07, 2016
06:00 AM PDT
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...
Speaker:
Philip Low, PhD
Presented At:Molecular Diagnostics
FEB 04, 2016
10:30 AM PST
C.E. CREDITS
FEB 04, 2016
10:30 AM PST
The reproducibility of animal studies is now critical to ensure that limited resources are used wisely and that efforts yield useable knowledge. At this time, IACUCs and other similar a...
Speaker:
Vatsala Naageshwaran, MS
,
Stacy Pritt, DVM, MS, MBA, CPIA, DACAW
Presented At:Laboratory Animal Sciences
JAN 15, 2016
04:00 AM PST
C.E. CREDITS
JAN 15, 2016
04:00 AM PST
DATE: January 15, 2016
TIME: 7am EST, 12pm UK, 1pm CET
With an increasing number of biomarkers and, often, limited availability of biopsy material, there is a growing need for multiplexed...
Speaker:
Matthew Silver, PhD
Sponsored By: Cell Signaling Technology,
Cell Signaling Technology
NOV 11, 2015
06:00 AM PST
NOV 11, 2015
06:00 AM PST
Cancer is complex, but recent findings are yielding a greater understanding of the disease. The tumor suppressor genes BRCA1 and BRCA2 are implicated in breast, ovarian, prostate, and other c...
Speaker:
Raed Samara, PhD
Presented At:Clinical Diagnostics and Research
SEP 30, 2015
07:30 AM PDT
SEP 30, 2015
07:30 AM PDT
We have been developing methods to target drugs specifically to pathologic cells, thereby avoiding collateral toxicity to healthy cells. In the case of cancer, we have exploited up-regulation...
Speaker:
Philip Low, PhD
Presented At:Cancer Research and Oncology
MAY 14, 2015
01:30 PM PDT
MAY 14, 2015
01:30 PM PDT
Germline cancer genetics became a reality with the cloning of the tumor suppressor gene RB1 for hereditary retinoblastoma in 1986 by Friend and Weinberg. The existence of cancer susceptibili...
Speaker:
Judy E Garber, MD, MPH
Presented At:Genetics and Genomics